 |
diazepam auto-injector |
|---|---|
| Trade Name | |
| Orphan Indication | Management of selected, refractory patients with epilepsy on stable regimens of antiepileptic drugs, who require intermittent use of diazepam to control bouts of increased seizure activity |
| USA Market Approval | USA |
| USA Designation Date | 2013-05-30 00:00:00 |
| Sponsor | Meridian Medical Technologies-a Pfizer subsidiary;445 Eastern Point Road;Groton, Connecticut, 06340 |
